Literature DB >> 19214466

[Rare cause of hypercalcemia].

C Spielhagen1, A Stier, K Hegenscheid, S Vogelgesang, M M Lerch, H Wallaschofski.   

Abstract

We report a 47-year-old women who presented to her general practitioner and our hospital with weight loss of unknown etiology. Eight years previously she had undergone a hemithyroidectomy for nodular goiter with one cold nodule. Laboratory results revealed hypercalcemia, evidence of primary hyperparathyroidism and computer tomography of the thorax showed bilateral pulmonary metastasis. After undergoing CT-guided biopsy of a metastasis, histology revealed an endocrine primary tumor with low parathyroid hormone expression. In view of the history, clinical and biochemical findings we diagnosed a recently metastasized functioning parathyroid carcinoma, which eight years previously has been labeled as a benign atypical thyroid adenoma. The patient underwent surgical resection of all detected metastases. Afterwards the serum calcium and parathyroid hormone levels normalized. Parathyroid carcinoma is an uncommon tumor. In the absence of pathognomonic diagnostic criteria a definitive pathological diagnosis of parathyroid carcinoma often is not possible. The treatment of parathyroid carcinoma is essentially surgical. Patients with parathyroid carcinoma mostly die from uncontrollable hypercalcemia rather than from other tumor-related complications.

Entities:  

Mesh:

Year:  2009        PMID: 19214466     DOI: 10.1007/s00108-008-2257-y

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  9 in total

Review 1.  Clinical review 122: Parathyroid carcinoma.

Authors:  E Shane
Journal:  J Clin Endocrinol Metab       Date:  2001-02       Impact factor: 5.958

2.  [Prophylactic parathyroidectomy for familial parathyroid carcinoma].

Authors:  O Gimm; K Lorenz; P Nguyen Thanh; U Schneyer; M Bloching; V M Howell; D J Marsh; B T Teh; U Krause; H Dralle
Journal:  Chirurg       Date:  2006-01       Impact factor: 0.955

3.  Successful combination chemotherapy for metastatic parathyroid carcinoma.

Authors:  R M Bukowski; L Sheeler; J Cunningham; C Esselstyn
Journal:  Arch Intern Med       Date:  1984-02

4.  Localization and reoperation results for persistent and recurrent parathyroid carcinoma.

Authors:  E Kebebew; C Arici; Q Y Duh; O H Clark
Journal:  Arch Surg       Date:  2001-08

5.  Histopathological variables and DNA cytometry in parathyroid carcinoma.

Authors:  L Bondeson; K Sandelin; L Grimelius
Journal:  Am J Surg Pathol       Date:  1993-08       Impact factor: 6.394

Review 6.  Diagnosis and treatment of patients with parathyroid carcinoma: an update and review.

Authors:  T Obara; Y Fujimoto
Journal:  World J Surg       Date:  1991 Nov-Dec       Impact factor: 3.352

Review 7.  Parathyroid carcinoma: clinical and pathologic features in 43 patients.

Authors:  A G Wynne; J van Heerden; J A Carney; L A Fitzpatrick
Journal:  Medicine (Baltimore)       Date:  1992-07       Impact factor: 1.889

8.  Parathyroid carcinoma: is there a role for adjuvant radiation therapy?

Authors:  Nathan D Munson; Robert L Foote; Robert C Northcutt; Robert D Tiegs; Lorraine A Fitzpatrick; Clive S Grant; Jonathan A van Heerden; Geoffrey B Thompson; Ricardo V Lloyd
Journal:  Cancer       Date:  2003-12-01       Impact factor: 6.860

9.  Prognostic factors in parathyroid cancer: a review of 95 cases.

Authors:  K Sandelin; G Auer; L Bondeson; L Grimelius; L O Farnebo
Journal:  World J Surg       Date:  1992 Jul-Aug       Impact factor: 3.352

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.